Patients with moderate RA as likely to need joint surgery as those with high disease
Rome, Italy, 10 June 2015: The results of a study presented today at the European League Against Rheumatism Annual Congress (EULAR 2015) Press Conference showed that patients with Rheumatoid Arthritis (RA) taking conventional DMARD therapy who have moderate disease activity have a similar risk of joint failure that requires surgery as those with high disease activity.
In some countries, additional treatment with a biological DMARD is based on a disease activity cut-off that excludes RA patients with moderate disease activity. These findings suggest it is not just ...






